ATE135013T1 - Verfahren zur erhöhung der rate der modifikation metastabiler bindungen - Google Patents

Verfahren zur erhöhung der rate der modifikation metastabiler bindungen

Info

Publication number
ATE135013T1
ATE135013T1 AT90910051T AT90910051T ATE135013T1 AT E135013 T1 ATE135013 T1 AT E135013T1 AT 90910051 T AT90910051 T AT 90910051T AT 90910051 T AT90910051 T AT 90910051T AT E135013 T1 ATE135013 T1 AT E135013T1
Authority
AT
Austria
Prior art keywords
rate
meta
modification
increase
stable bonds
Prior art date
Application number
AT90910051T
Other languages
English (en)
Inventor
Michael J Powell
Anthony R Rees
Paul M Booth
Wonpyo Hong
Richard Titmas
Richard Massey
Original Assignee
Igen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igen Inc filed Critical Igen Inc
Application granted granted Critical
Publication of ATE135013T1 publication Critical patent/ATE135013T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0002—Antibodies with enzymatic activity, e.g. abzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT90910051T 1989-06-08 1990-06-07 Verfahren zur erhöhung der rate der modifikation metastabiler bindungen ATE135013T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36407789A 1989-06-08 1989-06-08

Publications (1)

Publication Number Publication Date
ATE135013T1 true ATE135013T1 (de) 1996-03-15

Family

ID=23432905

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90910051T ATE135013T1 (de) 1989-06-08 1990-06-07 Verfahren zur erhöhung der rate der modifikation metastabiler bindungen

Country Status (10)

Country Link
EP (1) EP0476059B1 (de)
JP (2) JPH05503284A (de)
AT (1) ATE135013T1 (de)
AU (2) AU652342B2 (de)
CA (1) CA2018453A1 (de)
DE (1) DE69025761T2 (de)
DK (1) DK0476059T3 (de)
IL (1) IL94666A (de)
WO (1) WO1990015074A1 (de)
ZA (1) ZA904457B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236825A (en) * 1989-01-17 1993-08-17 Scripps Clinic And Research Foundation Polyvalent metal ion-containing antibody combining site catalysts
US5318897A (en) * 1989-04-25 1994-06-07 Igen, Inc. Monoclonal antibody and antibody components elicited to a polypeptide antigen ground state
US6235714B1 (en) * 1998-03-23 2001-05-22 Sudhir Paul Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079152A (en) * 1987-05-28 1992-01-07 Scripps Clinic And Research Foundation Antibody combining sites that exhibit stereoselective synthase activity, and methods using the same
US4900674A (en) * 1987-05-28 1990-02-13 Scripps Clinic And Research Foundation Antibody combining sites that exhibit amide or ester synthase activity
ZA893284B (en) * 1988-05-04 1990-03-28 Igen Inc Peptide analogs and their use as haptens to elicit catalytic antibodies

Also Published As

Publication number Publication date
CA2018453A1 (en) 1990-12-08
EP0476059A4 (en) 1992-06-03
IL94666A (en) 1997-02-18
DE69025761D1 (de) 1996-04-11
AU652342B2 (en) 1994-08-25
ZA904457B (en) 1992-02-26
AU5842490A (en) 1991-01-07
DK0476059T3 (da) 1996-07-29
WO1990015074A1 (en) 1990-12-13
EP0476059A1 (de) 1992-03-25
JPH1180195A (ja) 1999-03-26
EP0476059B1 (de) 1996-03-06
AU669310B2 (en) 1996-05-30
DE69025761T2 (de) 1996-07-18
JPH05503284A (ja) 1993-06-03
AU7903594A (en) 1995-03-30

Similar Documents

Publication Publication Date Title
ATE404587T1 (de) Verfahren zur identifizierung von induktoren und inhibitoren proteolytischer antikörper, zusammensetzungen sowie deren verwendungen
ES2068907T3 (es) Secuencias de nucleotidos que codifican una proteina con actividad ureasica.
HU9600692D0 (en) Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds
DE69534374D1 (de) Methoden und zubehör zur immunisierung von wirtsorganismen durch verabreichung nackter polynucleotide , welche für antigene peptide codieren
PT699755E (pt) Metodo para obtencao de imunoglobulinas modificadas com imunogenicidade reduzida de dominios variaveis de anticorpos de murideo composicoes que as contem
DE69800716D1 (de) Neues verfahren zur herstellung von anti-humanen antigenrezeptoren und deren verwendungen
DE69227041D1 (de) Expression und reinigung von rekombinantem, löslichem gewebefaktor
GR3018371T3 (en) Method for identifying or determining proteins and applications therefor.
ATE126531T1 (de) Verfahren zur gewinnung von natürlich hergestelltem chymosin.
DE69025761D1 (de) Verfahren zur erhöhung der rate der modifikation metastabiler bindungen
NO986218D0 (no) FremgangsmÕte til Õ bestemme nµrvµr av hjerneprotein S-100
PT744027E (pt) Utilizacao de metodos para identificar oligopeptidos de sinal hidrofilicos
EP0728015A4 (de) Kombinatorische polypeptidantigene
DE59004279D1 (de) Verfahren zur C-terminalen Modifizierung von Proteinen.
DE3650570D1 (de) Verfahren und Reagenz zur Bestimmung des Follikel stimulierenden Hormons sowie hierzu geeignete monoklonale Antikörper
AR002004A1 (es) Proteina slam, anticuerpo o un fragmento del mismo que se fija a dicha proteina, metodo de purificacion, acido nucleico que codifica dicha proteina,vector de expresion, equipo que la contiene, metodo de deteccion, metodo de modulacion y metodo para preparar una composicion farmaceutica.
ATE307201T1 (de) Srcr domäne-enthaltendes protein
EP0351244A3 (de) Antikörper und Methoden für ihre Verwendung in Immuntests
AU2562088A (en) Detection of tumor-associated markers in biological fluids
DE59914155D1 (de) Neue peptidfragmente zur reinigung von proteinen
ATE128232T1 (de) Verfahren zur bestimmung von antigenen und/oder antikörpern in menschlichen körperflüssigkeiten sowie set zur durchführung des verfahrens.
WO2003040394A3 (en) Production of recombinant proteins in vivo and use for generating antibodies

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee